Purifying Clay Mask Base

1. INCI & CAS

INCI: Kaolin · CAS: 1332-58-7

2. Role in the formula

This guide treats kaolin as a cosmetic clay made of hydrated aluminum silicate; it does not establish drug absorbency.

3. Typical use levels (formulation guide)

• Masks: 5–20% for the formula.
• The stated reference for scrubs is 2–8%.

Wet the clay before adding to a gum phase to limit clumps.

4. Regulatory sources & global compliance

• If CosIng lists Kaolin, that listing remains ingredient information; check rules for the intended market and use.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Kaolin is used, to be assessed before release of the finished cosmetic.
• Review the documentation for the actual Kaolin grade and the filing requirements for the target market.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; the note establishes neither drug approval nor OTC-monograph status with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; select packaging with the formula's oxidation sensitivity in mind; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Kaolin highlights kaolin clay.

• This product entry cannot substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The documented facts for Kaolin does not establish skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Bentonite · CAS: 1302-78-9

2. Role in the formula

Bentonite is a swelling clay. It can tighten a mask as it dries. Not a detox drug claim.

3. Typical use levels (formulation guide)

• Formulation guidance for masks: 1–5% for the formula.

Hydrate separately; it can lump.

4. Regulatory sources & global compliance

• CosIng provides reference information for Bentonite; confirm the specific grade and intended use against market requirements.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety assessment covering the complete formulation with Bentonite in the final product context.
• Compare the received Bentonite material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it makes no claim of drug or OTC authorization and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; select packaging with the formula's oxidation sensitivity in mind; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Bentonite as part of a cosmetic direction focused on bentonite mask.

• The development record provides no basis for drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This Bentonite listing provides no basis for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• The stated reference for gels and serums is 3–8% in this reference.
• The formulation record indicates 2–5% for creams.
• The rinse-off use-level reference is 2–4% in this reference.

Use the water phase to introduce Glycerin; no melting stage is required.

4. Regulatory sources & global compliance

• A CosIng entry naming Glycerin does not by itself approve the purchased grade or complete cosmetic.
• Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Glycerin before the cosmetic is placed on the EU market.
• Confirm the actual Glycerin grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it does not establish drug approval or OTC-monograph status while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• The available ingredient details cannot substantiate drug effects, clinical cures, or unsupported product certifications.
• This reference for Glycerin does not establish whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.